Page last updated: 2024-11-03

propranolol and Urethral Neoplasms

propranolol has been researched along with Urethral Neoplasms in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Urethral Neoplasms: Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itesako, T1
Eura, R1
Okamoto, Y1
Tatarano, S1
Yoshino, H1
Nishimura, H1
Yamada, Y1
Enokida, H1
Nakagawa, M1

Other Studies

1 other study available for propranolol and Urethral Neoplasms

ArticleYear
Oral Propranolol in a Child With Infantile Hemangioma of the Urethra.
    Urology, 2018, Volume: 122

    Topics: Adrenergic beta-Antagonists; Child, Preschool; Cystoscopy; Hemangioma, Capillary; Hemorrhage; Humans

2018